{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:08:04Z","timestamp":1793747284601,"version":"4.6.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bacterial plasminogen activators are commonplace among microbial pathogens, implying a central role of host plasmin in supporting bacterial virulence. Group A streptococci (GAS) secrete streptokinase, a specific activator of human plasminogen (PLG). The critical contribution of the streptokinase-PLG interaction to GAS pathogenicity was recently demonstrated using mice expressing human PLG. To examine the importance of thrombin generation in antimicrobial host defense, we challenged mice with deficiency of factor V (FV) in either the plasma or platelet compartment. Reduction of FV in either pool resulted in markedly increased mortality after GAS infection, with comparison to heterozygous F5-deficient mice suggesting a previously unappreciated role for the platelet FV pool in host defense. Mice with complete deficiency of fibrinogen also demonstrated markedly increased mortality to GAS infection relative to controls. Although FV Leiden may be protective in the setting of severe sepsis in humans, no significant survival advantage was observed in GAS-infected mice carrying the FV Leiden mutation. Taken together, our data support the hypothesis that local thrombosis\/fibrin deposition limits the survival and dissemination of at least a subset of microbial pathogens and suggest that common variation in hemostatic factors among humans could affect host susceptibility to a variety of infectious diseases.<\/jats:p>","DOI":"10.1182\/blood-2008-07-170506","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T22:13:44Z","timestamp":1228342424000},"page":"1358-1364","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":108,"title":["Reduced thrombin generation increases host susceptibility to group A streptococcal infection"],"prefix":"10.1182","volume":"113","author":[{"given":"Hongmin","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Missouri\u2013Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Wang","sequence":"additional","affiliation":[{"name":"Life Science Institute, University of Michigan, Ann Arbor;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Degen","sequence":"additional","affiliation":[{"name":"Children's Hospital Research Foundation and University of Cincinnati College of Medicine, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ginsburg","sequence":"additional","affiliation":[{"name":"Life Science Institute, University of Michigan, Ann Arbor;"},{"name":"Howard Hughes Medical Institute, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111721333351700_B1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases.","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2019111721333351700_B2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections of skin and soft tissues.","volume":"334","author":"Bisno","year":"1996","journal-title":"N Engl J Med"},{"key":"2019111721333351700_B3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/444505","article-title":"Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles\u2014report of a National Institute of Allergy and Infectious Diseases workshop.","volume":"41","author":"Bisno","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019111721333351700_B4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1286-4579(02)01565-4","article-title":"The molecular basis of Streptococcus equi infection and disease.","volume":"4","author":"Harrington","year":"2002","journal-title":"Microbes Infect"},{"key":"2019111721333351700_B5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0305-0491(83)90345-0","article-title":"Species specificity of streptokinase.","volume":"75","author":"Marcum","year":"1983","journal-title":"Comp Biochem Physiol B"},{"key":"2019111721333351700_B6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0038-1648921","article-title":"Characterization of a novel streptokinase produced by Streptococcus equisimilis of non-human origin.","volume":"72","author":"Nowicki","year":"1994","journal-title":"Thromb Haemost"},{"key":"2019111721333351700_B7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/infdis\/164.3.515","article-title":"Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation.","volume":"164","author":"McCoy","year":"1991","journal-title":"J Infect Dis"},{"key":"2019111721333351700_B8","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1128\/IAI.67.12.6487-6495.1999","article-title":"Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.","volume":"67","author":"Schroeder","year":"1999","journal-title":"Infect Immun"},{"key":"2019111721333351700_B9","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1074\/jbc.275.19.14579","article-title":"Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen.","volume":"275","author":"Boxrud","year":"2000","journal-title":"J Biol Chem"},{"key":"2019111721333351700_B10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.1101245","article-title":"Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.","volume":"305","author":"Sun","year":"2004","journal-title":"Science"},{"key":"2019111721333351700_B11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/2906","article-title":"Switching serine protease specificity.","volume":"5","author":"Esmon","year":"1998","journal-title":"Nat Struct Biol"},{"key":"2019111721333351700_B12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague.","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"key":"2019111721333351700_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1655727","article-title":"Plasminogen activation by invasive human pathogens.","volume":"77","author":"Boyle","year":"1997","journal-title":"Thromb Haemost"},{"key":"2019111721333351700_B14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1086\/319291","article-title":"Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection.","volume":"183","author":"Engleberg","year":"2001","journal-title":"J Infect Dis"},{"key":"2019111721333351700_B15","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1101\/gad.9.16.2020","article-title":"Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.","volume":"9","author":"Suh","year":"1995","journal-title":"Genes Dev"},{"key":"2019111721333351700_B16","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI20741","article-title":"Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2\/Mac-1 is critical for host inflammatory response in vivo.","volume":"113","author":"Flick","year":"2004","journal-title":"J Clin Invest"},{"key":"2019111721333351700_B17","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2003-04-1225","article-title":"The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis.","volume":"102","author":"Sun","year":"2003","journal-title":"Blood"},{"key":"2019111721333351700_B18","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V96.13.4222","article-title":"Spontaneous thrombosis in mice carrying the factor V Leiden mutation.","volume":"96","author":"Cui","year":"2000","journal-title":"Blood"},{"key":"2019111721333351700_B19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1538-7836.2005.01590.x","article-title":"Inherited defects of coagulation factor V: the hemorrhagic side.","volume":"4","author":"Asselta","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111721333351700_B20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors.","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"2019111721333351700_B21","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","article-title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation.","volume":"264","author":"Esmon","year":"1989","journal-title":"J Biol Chem"},{"key":"2019111721333351700_B22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/153537020422901104","article-title":"Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.","volume":"229","author":"Flick","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"2019111721333351700_B23","first-page":"344","article-title":"Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.","volume":"80","author":"De","year":"1995","journal-title":"Haematologica"},{"key":"2019111721333351700_B24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004390100593","article-title":"Genetic risk factors of venous thrombosis.","volume":"109","author":"Franco","year":"2001","journal-title":"Hum Genet"},{"key":"2019111721333351700_B25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"2019111721333351700_B26","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2003-06-1789","article-title":"Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.","volume":"102","author":"Kerlin","year":"2003","journal-title":"Blood"},{"key":"2019111721333351700_B27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/384066a0","article-title":"Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.","volume":"384","author":"Cui","year":"1996","journal-title":"Nature"},{"key":"2019111721333351700_B28","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1073\/pnas.95.13.7597","article-title":"Prothrombin deficiency results in embryonic and neonatal lethality in mice.","volume":"95","author":"Sun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721333351700_B29","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1073\/pnas.95.13.7603","article-title":"Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.","volume":"95","author":"Xue","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721333351700_B30","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood-2003-10-3578","article-title":"Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.","volume":"103","author":"Castoldi","year":"2004","journal-title":"Blood"},{"key":"2019111721333351700_B31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1538-7933.2003.00617.x","article-title":"Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system.","volume":"2","author":"Allen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019111721333351700_B32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation.","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"2019111721333351700_B33","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1074\/jbc.M308600200","article-title":"Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V\/Va.","volume":"279","author":"Gould","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111721333351700_B34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: bridging inflammation and cardiovascular disease.","volume":"100","author":"von","year":"2007","journal-title":"Circ Res"},{"key":"2019111721333351700_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2005.12.005","article-title":"The emerging role of platelets in adaptive immunity.","volume":"238","author":"Elzey","year":"2005","journal-title":"Cell Immunol"},{"key":"2019111721333351700_B36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/meth.2000.0980","article-title":"The interaction of pathogens with humans.","volume":"21","author":"Boyle","year":"2000","journal-title":"Methods"},{"key":"2019111721333351700_B37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway.","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"2019111721333351700_B38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.genom.3.022502.103149","article-title":"Balanced polymorphism selected by genetic versus infectious human disease.","volume":"3","author":"Dean","year":"2002","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2019111721333351700_B39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-2143(99)90095-1","article-title":"Use of the plasminogen activation system by microorganisms.","volume":"134","author":"Coleman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"2019111721333351700_B40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(04)00057-1","article-title":"M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.","volume":"116","author":"Herwald","year":"2004","journal-title":"Cell"},{"key":"2019111721333351700_B41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1574-6976.2001.tb00590.x","article-title":"Bacterial plasminogen activators and receptors.","volume":"25","author":"Lahteenmaki","year":"2001","journal-title":"FEMS Microbiol Rev"},{"key":"2019111721333351700_B42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1152\/physiol.00059.2005","article-title":"The interaction between pathogens and the host coagulation system.","volume":"21","author":"Sun","year":"2006","journal-title":"Physiology"},{"key":"2019111721333351700_B43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1152\/physiolgenomics.00077.2002","article-title":"Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice.","volume":"11","author":"Peters","year":"2002","journal-title":"Physiol Genom"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/6\/1358\/1312454\/zh800609001358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/6\/1358\/1312454\/zh800609001358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T17:37:37Z","timestamp":1632505057000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/6\/1358\/25650\/Reduced-thrombin-generation-increases-host"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,5]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,2,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-170506","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1157076.617175","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,5]]}}}